Monica Armida

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review.

Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review.

Journal: International journal of molecular sciences

Published: December 14, 2023

Effects of a gut-selective integrin-targeted therapy in male mice exposed to early immune activation, a model for the study of autism spectrum disorder.

Effects of a gut-selective integrin-targeted therapy in male mice exposed to early immune activation, a model for the study of autism spectrum disorder.

Journal: Brain, behavior, and immunity

Published: June 15, 2023

Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences.

Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences.

Journal: Neuroscience

Published: April 30, 2021

Adenosine A2A receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice.

Adenosine A2A receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice.

Journal: Translational psychiatry

Published: October 06, 2020

Beneficial Effects of Fingolimod on Social Interaction, CNS and Peripheral Immune Response in the BTBR Mouse Model of Autism.

Beneficial Effects of Fingolimod on Social Interaction, CNS and Peripheral Immune Response in the BTBR Mouse Model of Autism.

Journal: Neuroscience

Published: December 20, 2019

Modulating P1 Adenosine Receptors in Disease Progression of SOD1G93A Mutant Mice.

Modulating P1 Adenosine Receptors in Disease Progression of SOD1G93A Mutant Mice.

Journal: Neurochemical research

Published: October 04, 2018

Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington's disease.

Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington's disease.

Journal: Purinergic signalling

Published: December 29, 2017

The adenosine A2A receptor agonist T1-11 ameliorates neurovisceral symptoms and extends the lifespan of a mouse model of Niemann-Pick type C disease.

The adenosine A2A receptor agonist T1-11 ameliorates neurovisceral symptoms and extends the lifespan of a mouse model of Niemann-Pick type C disease.

Journal: Neurobiology of disease

Published: July 12, 2017

Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.

Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: July 27, 2016

Aberrant self-grooming as early marker of motor dysfunction in a rat model of Huntington's disease.

Aberrant self-grooming as early marker of motor dysfunction in a rat model of Huntington's disease.

Journal: Behavioural brain research

Published: May 23, 2016

Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.

Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.

Journal: Journal of neurochemistry

Published: July 29, 2015

Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.

Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.

Journal: Disease models & mechanisms

Published: July 20, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026